A new study published in the journal Cell Immunology has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis and cannabinoids – has neuroinflammatory capabilities. According to the study; “Here we showed that Gp1a, a highly selective CB2 [cannabinoid receptor 2] agonist, with a four log higher affinity for CB2 than CB1, reduced clinical scores and facilitated recovery in EAE [experimental autoimmune encephalomyelitis, a disease of the central nervous system] in conjunction with long term reduction in demyelination and axonal loss.” The study continues; “This is the first report on the in vivo CB2-mediated Gp1a…
Author: WebTeam
A new clinical study published in the journal Pharmacology and by the National Institute of Health has found that cannabis is effective in treating Chron’s disease, which is a form of inflammatory bowel disease (IBD). According to researchers at the Institute of Experimental and Clinical Pharmacology at the Medical University of Graz in Austria; “In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.” They…
Following the success of last year’s ride, the MC Bike Tour returns with the aim to raise over €50,000 to support scientific research into how cannabis treats cancer. From March 11-13th 2014, 50 riders will ride on a 400km journey. The MC Bike Tour will arrive 3 days later to a heroes’ welcome at the Spannabis Expo in Barcelona. Following on from the success of the 2013 tour which raised €50,000, the Bike Tour is looking to increase media exposure and awareness for medical cannabis. The money raised is helping to fund research by scientists at Madrid’s Complutense University, who…
Here’s the long version of the Medical Cannabis Bike Tour 2013 – with cyclists from all over Europe taking part, the MC Bike Tour was an epic 385km adventure through the mountains from Madrid to Valencia, in this video you find a full description of the ride, the team doing research in Madrid who got the 2013 prize and the arrival at the GrowMed Expo Valencia.Enjoy and join us next year! medicalcannabis-biketour.comfacebook.com/medicalbiketour
The situation in Spain is a special case. After the Spanish peninsula was characterised as “the Netherlands of the South”, the number of social cannabis clubs sky-rocketed. In some cases, however, it is difficult to identify the altruists amidst all the uproar. As ever, a handful of opponents who are trying to increase their numbers in order to uphold the bad reputation of the opposition are having to confront the countless fighters for the cause. The clubs are now working hard to seize a place in a society that is gradually beginning to accept the legalisation of cannabis. What’s more,…
A new study published in the journal Chemotherapy has found that cannabinoid receptor activation – something done naturally by cannabis and cannabinoids – can lead to the death of gastric cancer cells. For the study, researchers at the Catholic University of Korea’s Department of Internal Medicine studied the effects of a cannabinoid receptor agonist (which cannabis is) on mice injected with gastric cancer cells. It was found that, after 14 days, “Tumor volume decreased by 30% in the WIN 55,212-2 [a cannabinoid receptor agonist] -treated group.. Apoptotic [self-destructed] cells were found more commonly in the WIN 55,212-2 treatment group than…
A new study published in the journal PLoS One as well as the National Institute of Health has found that cannabis may serve as a treatment for Hodgkin lymphoma, which is a cancer of lymph tissue (found in the spleen, liver, bone marrow and other areas). For the study, researchers at Goethe-University, Leipzig University and Martin-Luther-University Halle-Wittenberg “examined the distribution of CB1 [cannabinoid receptor 1] protein in primary cases of HL (Hodgkin lymphoma). Using lymphoma derived cell lines, the role of CB1 signaling on cell survival was investigated.” After conducting the study, researchers concluded that; “The present study identifies CB1…
A new study published in this month’s issue of the journal Epilepsy Behavior has found that many parents with epileptic children are turning to cannabis-based medicines to treat their seizures, and in a large majority of instances, it’s successful in doing so. “Severe childhood epilepsies are characterized by frequent seizures, neurodevelopmental delays, and impaired quality of life. In these treatment-resistant epilepsies, families often seek alternative treatments”, begins the study’s abstract. “This survey explored the use of cannabidiol-enriched cannabis in children with treatment-resistant epilepsy.” For the study, researchers at the Department of Neurology at Stanford University examined 19 parents who have…
A new study published this month by the journal Reproduction, and published online by the National Institute of Health, has found exciting new evidence to suggest that proper cannabinoid signalling can lead to health placental development during pregnancy, and an overall good pregnancy outcome. According to the study’s researchers; “whereas the loss of ψm [mitochondrial membrane potential] and ROS/RNS [reactive oxygen/nitrogen species] generation were significantly attenuated by both Cannabinoid Receptors 1 and 2 (CB1, CB2) antagonists, the increase in caspase 3/7 and 9 activities and cell viability loss were only reversed by CB2 antagonist; the blockage of the eCB membrane…
A recent study published by the National Institute of Health and the journal Translational Stroke Research has found that activation of the body’s cannabinoid receptors can reduce the harmful effects of strokes, and can even prevent them entirely. For the study researchers at the Department of Pathology at Temple University School of Medicine used mouse models to examine the effects of activating the body’s cannabinoid receptors on transient middle cerebral artery occlusion/reperfusion injury (MCAO/R). They found that; “In conclusion, administration of the CB2R agonist/CB1R antagonist combination causes a significant reduction in infarct size in the MCAO/R model.” According to the…
